BOTTOSSO, MICHELE

BOTTOSSO, MICHELE  

Università di Padova  

Mostra records
Risultati 1 - 20 di 25 (tempo di esecuzione: 0.05 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomes 2025 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaBonomi, GiorgioMassa, DavideDieci, Maria VittoriaGuarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications 2025 Griguolo, GDieci, M VBottosso, MMiglietta, FZanconato, FSchiavi, FFassan, MDei Tos, A PGuarneri, V + ESMO OPEN - -
Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a systematic review and meta-analysis 2025 Bottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGriguolo, GaiaGuarneri, Valentina + THE BREAST - -
Temporal evolution of breast cancer brain metastases treatments and outcomes 2025 Bottosso, MicheleGriguolo, GaiaMiglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + NPJ BREAST CANCER - -
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 2024 Bottosso, MicheleDieci, Maria VittoriaMiglietta, FedericaBonanno, LauraGuarneri, ValentinaGriguolo, GaiaPasello, Giulia + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome 2024 Bottosso, MicheleGuarneri, Valentina + JCO PRECISION ONCOLOGY - -
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer 2024 Bottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, ValentinaGriguolo, Gaia + CLINICAL CANCER RESEARCH - -
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome 2024 Bottosso, MicheleGuarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + CLINICAL CANCER RESEARCH - -
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleDei Tos, Angelo PaoloGuarneri, ValentinaDieci, Maria VittoriaFassan, Matteo + JOURNAL OF CLINICAL PATHOLOGY - -
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases 2023 Bottosso, MicheleGriguolo, GaiaMiglietta, FedericaVernaci, GraziaGuarneri, ValentinaDieci, Maria Vittoria + BRITISH JOURNAL OF CANCER - -
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients 2023 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + INTERNATIONAL JOURNAL OF CANCER - -
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 2022 Griguolo, GaiaTosi, AnnaDieci, Maria VittoriaVentura, AnnaveraBottosso, MicheleMiglietta, FedericaFassan, MatteoConte, PierFrancoRosato, AntonioGuarneri, Valentina + NEURO-ONCOLOGY - -
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 2022 Zarrilli G.Angerilli V.Cappellesso R.Galuppini F.Pennelli G.Farinati F.Nicole L.Savarino E.Griguolo G.Bottosso M.Dieci M. V.Guarneri V.Dei Tos A. P.Fassan M. + PATHOLOGY RESEARCH AND PRACTICE - -
Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2− breast cancer: Available evidence and clinical implications 2022 Griguolo G.Bottosso M.Vernaci G.Miglietta F.Dieci M. V.Guarneri V. CANCER TREATMENT REVIEWS - -
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 2022 Federica MigliettaGaia GriguoloMichele BottossoTommaso GiarratanoMatteo FassanMatilde CacciatoreElisa GenovesiDebora De BartoloGrazia VernaciOttavia AmatoFrancesca PorraPierFranco ConteValentina GuarneriMaria Vittoria Dieci + NPJ BREAST CANCER - -
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial 2022 Guarneri, ValentinaDieci, Maria VittoriaGriguolo, GaiaMiglietta, FedericaBottosso, MicheleGiorgi, Carlo AlbertoConte, PierFranco + EBIOMEDICINE - -
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort 2022 Bottosso, MicheleDieci, Maria VittoriaGuarneri, ValentinaGriguolo, Gaia + INTERNATIONAL JOURNAL OF CANCER - -
Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival 2022 Miglietta, FBottosso, MGriguolo, GDieci, M VGuarneri, V ESMO OPEN - -
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability? 2022 Miglietta, FedericaMarini, SabrinaGriguolo, GaiaVernaci, Grazia MariaBottosso, MicheleDieci, Maria VittoriaGuarneri, Valentina + CANCER TREATMENT REVIEWS - -